Nitric oxide-induced mitochondrial dysfunction: Implications for neurodegeneration

Free Radical Biology and Medicine

Volumn 34, Issue 3, 2003, Pages 287-303

  Stewart, Victoria C ^a   Heales, Simon J R ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Electron transport chain; Free radicals; Glia; Mitochondria; Neurodegeneration; Neuron; Nitric oxide

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCYSTEINE; AMPHETAMINE; ANTIOXIDANT; BETA INTERFERON; CANNABINOID DERIVATIVE; COCAINE; CYTOCHROME C OXIDASE; CYTOKINE; GLUTAMIC ACID; GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; MELATONIN; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PARACETAMOL; PEROXYNITRITE; PSYCHOSTIMULANT AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUINOL CYTOCHROME C REDUCTASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN NERVE CELL; CELL ENERGY; CELL SURVIVAL; CELL TYPE; CHRONIC INFLAMMATION; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG ABUSE; DRUG EFFECT; DRUG MECHANISM; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUTATHIONE METABOLISM; HUMAN; INFECTION; LIVER TOXICITY; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RESPIRATORY CHAIN; REVIEW;

EID: 0037303479     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01327-8     Document Type: Review

References (197)

1. 2+-independent nitric oxide synthases. FEBS Lett. 291:1991;145-149.
2. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
3. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide physiology, pathophysiology, and pharmacology . Pharmacol. Rev. 43:1991;109-142.
4. Bredt D.S., Snyder S.H. Nitric oxide a physiologic messenger molecule . Annu. Rev. Biochem. 63:1994;175-195.
5. Dawson V.L., Dawson T.M. Nitric oxide neurotoxicity. J. Chem. Neuroanat. 10:1996;179-190.
6. Lacza Z., Puskar M., Figueroa J.P., Zhang J., Rajapakse N., Busija D.W. Mitochondrial nitric oxide synthase is constitutively active and is functionally upregulated in hypoxia. Free Radic. Biol. Med. 31:2001;1609-1615.
7. Murphy S., Simmons M.L., Agull L., Garca A., Feinstein D.L., Galea E., Reis D.J., Minc-Golomb D., Schwartz J.P. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16:1993;323-328.
8. Minc-Golomb D., Yadid G., Tsarfaty I., Resau J.H., Schwartz J.P. In vivo expression of inducible nitric oxide synthase in cerebellar neurons. J. Neurochem. 66:1996;1504-1509.
9. Moro M.A., DeAlba J., Leza J.C., Lorenzo P., Fernandez A.P., Bentura M.L., Bosca L., Rodrigo J., Lizasoain I. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur. J. Neurosci. 10:1998;445-456.
10. Colasanti M., Persichini T., Fabrizi C., Cavalieri E., Venturini G., Ascenzi P., Lauro G.M., Suzuki H. Expression of a NOS-3-like protein in human astroglial cell culture. Biochem. Biophys. Res. Commun. 252:1998;552-555.
11. Kugler P., Drenckhahn D. Astrocytes and Bergmann glia as an important site of nitric oxide synthase 1. Glia. 16:1996;165-173.
12. DeGroot C.J.A., Ruuls S., Theeuwes J.W.M., Dijkstra C.D., Van der Walk P. Immunocytochemical characterization of the expression of inducible and consitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:1997;10-20.
13. Liu J., Zhao M.L., Brosnan C.F., Lee S.C. Expression of type II nitric oxide synthase in primary human astrocytes and microglia role of IL-1 β and Il-1 receptor antagonists . J. Immunol. 157:1996;3569-3576.
14. Merrill J.E., Murphy S.P., Mitrovic B., Mackenzie-Graham A., Dapp J.C., Ding M., Griscavage J., Ignarro L.J., Lowenstein C.J. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J. Neurosci. Res. 48:1997;372-384.
15. Keilhoff G., Seidel B., Wolf G. Absence of nitric oxide synthase in rat oligodendrocytes a light and electron microscopic study . Acta Histochem. 100:1998;409-417.
16. Hewett J.A., Hewett S.J., Winkler S., Pfeiffer S.E. Inducible nitric oxide synthase expression in cultures enriched for mature oligodendrocytes is due to microglia. J. Neurosci. Res. 56:1999;189-198.
17. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S.V., Sucher N.J., Loscalzo J., Singel D.J., Stamler J.S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
18. Pedersen P.L. The machine that makes ATP. Curr. Biol. 4:1994;1138-1141.
19. Davey G.P., Clark J.B. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66:1996;1617-1624.
20. Boveris A., Cadenas E., Stoppani A.O. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem. J. 156:1976;435-444.
21. Han D., Williams E., Cadenas E. Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem. J. 353:2001;411-416.
22. Turrens J.F., Boveris A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191:1980;421-427.
23. Radi R., Rodrguez M., Castro L., Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:1994;89-95.
24. Poderoso J.J., Lisdero C., Schopfer F., Riobo N., Carreras M.C., Cadenas E., Boveris A. The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol. J. Biol. Chem. 274:1999;37709-37716.
25. Smeitink J., van den Heuvel L. Human mitochondrial complex I in health and disease. Am. J. Hum. Genet. 64:1999;1505-1510.
26. Drapier J., Hibbs J.B. Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J. Immunol. 140:1988;2829-2838.
27. Cooper C.E., Brown G.C. The interactions between nitric oxide and brain nerve terminals as studied by electron paramagnetic resonance. Biochem. Biophys. Res. Commun. 212:1995;404-412.
28. Geng Y., Hansson G.K., Holme E. Interferon-γ and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ. Res. 71:1992;1268-1276.
29. Stadler J., Billiar T.R., Curran R.D., Stuehr D.J., Ochoa J.B., Simmons R.L. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am. J. Physiol. 260:1991;C910-C916.
30. Cassina A., Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch. Biochem. Biophys. 328:1996;309-316.
31. Riobo N.A., Clementi E., Melani M., Boveris A., Cadenas E., Moncada S., Poderoso J.J. Nitric oxide inhibits mitochondrial NADH ubiquinone reductase activity through peroxynitrite formation . Biochem. J. 359:2000;139-145.
32. Bolaos J.P., Peuchen S., Heales S.J.R., Land J.M., Clark J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63:1994;910-916.
33. Bolaos J.P., Heales S.J.R., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain differential susceptibility of neurones and astrocytes in primary cultures . J. Neurochem. 64:1995;1965-1972.
34. Stewart V.C., Giovannoni G., Land J.M., McDonald W.I., Clark J.B., Heales S.J.R. Pretreatment of astrocytes with interferon-α/β impairs interferon-γ induction of nitric oxide synthase. J. Neurochem. 68:1997;2547-2551.
35. Brookes P.S., Land J.M., Clark J.B., Heales S.J.R. Peroxynitrite and brain mitochondria evidence for increased proton leak . J. Neurochem. 70:1998;2195-2202.
36. Barker J.E., Bolaos J.P., Land J.M., Clark J.B., Heales S.J.R. Glutathione protects astrocytes from peroxynitrite-mediated mitochondrial damage implications for neuronal/astrocytic trafficking and neurodegeneration . Dev. Neurosci. 18:1996;391-396.
37. Clementi E., Brown G.C., Feelisch M., Moncada S. Persistent inhibition of cell respiration by nitric oxide crucial role of S-nitrosylation of mitochondrial complex I and protective role of glutathione . Proc. Natl. Acad. Sci. USA. 95:1998;7631-7636.
38. Beltran B., Orsi A., Clementi E., Moncada S. Oxidative stress and S-nitrosylation of proteins in cells. Br. J. Pharmacol. 129:2000;953-960.
39. Singh S.P., Wishnok J.S., Keshive M., Deen W.M., Tannenbaum S.R. The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl. Acad. Sci. USA. 93:1996;14428-14433.
40. Vasquez O.L., Almeida A., Bolaos J.P. Depletion of glutathione upregulates mitochondrial complex I expression in glial cells. J. Neurochem. 76:2001;1593-1596.
41. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 275:2000;26096-26101.
42. Hirawake H., Taniwaki M., Tamura A., Amino H., Tomitsuka E., Kita K. Characterization of the human SDHD gene encoding the small subunit of cytochrome b (cybS) in mitochondrial succinate-ubiquinone oxidoreductase. Biochim. Biophys. Acta. 1412:1999;295-300.
43. 1 particle, and reconstitution of succinate cytochrome c reductase. Methods Enzymol. 10:1967;216-225.
44. Rustin P., Chretien D., Bourgeron T., Greard B., Rotig A., Saudbray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta. 228:1994;35-51.
45. Schopfer F., Riobo N., Carreras M.C., Alvarez B., Radi R., Boveris A., Cadenas E., Poderoso J.J. Oxidation of ubiquinol by peroxynitrite implications for protection of mitochondria against nitrosative stress . Biochem. J. 349:2000;35-42.
46. Mitrovic B., Ignarro L.J., Montestruque S., Smoll A., Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination its differential effects on primary glial cells in vitro . Neuroscience. 61:1994;575-585.
47. Tsukihara T., Aoyama H., Yamashita E., Tomizaki T., Yamaguchi H., Shinzawa-Itoh K., Nakashima R., Yaono R., Yoshikawa S. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 Å Science. 272:1996;1136-1144.
48. Paradies G., Petrosillo G., Pistolese M., Ruggiero F.M. The effect of reactive oxygen species generated from mitochondrial electron transport chain on the cytochrome c oxidase and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 466:2000;323-326.
49. Keilin D., Hartree E.F. Cytochrome and cytochrome oxidase. Proc. R. Soc. Lond. B Biol. Sci. 127:1939;167-191.
50. Brudvig G.W., Stevens T.H., Chan S.I. Reactions of nitric oxide with cytochrome c oxidase. Biochemistry. 19:1980;5275-5285.
51. Radi R. Reactions of nitric oxide with metalloproteins. Chem. Res. Toxicol. 9:1996;828-835.
52. Brown G.C., Cooper C.E. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356:1994;295-298.
53. Brown G.C. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett. 369:1995;136-139.
54. Zhao X.J., Sampath V., Caughey W.S. Cytochrome c oxidase catalysis of the reduction of nitric oxide to nitrous oxide. Biochem. Biophys. Res. Commun. 212:1995;1054-1060.
55. Poderoso J.J., Carreras M.C., Lisdero C.L., Riobo N.A., Schopfer F., Boveris A.D. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328:1996;85-92.
56. Bolaos J.P., Heales S.J.R., Peuchen S., Barker J.E., Land J.M., Clark J.B. Nitric oxide-mediated mitochondrial damage a potential neuroprotective role for glutathione . Free Radic. Biol. Med. 21:1996;995-1001.
57. Packer M.A., Porteous C.M., Murphy M.P. Superoxide production by mitochondria in the presence of nitric oxide forms peroxynitrite. Biochem. Mol. Biol. Int. 40:1996;527-534.
58. Sharpe M.A., Cooper C.E. Interaction of peroxynitrite with mitochondrial cytochrome oxidase. J. Biol. Chem. 273:1998;30961-30972.
59. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
60. White D.A. The phospholipid composition of mammalian tissues. Ansell G.B., Hawthorne J.N., Dawson R.M.C. Form and function of phospholipids. vol. 3:1973;441-482 Elsevier Science Ltd, Amsterdam.
61. Heales S.J.R., Bolaos J.P., Land J.M., Clark J.B. Trolox protects mitochondrial complex IV from nitric oxide-mediated damage in astrocytes. Brain Res. 668:1994;243-245.
62. Hogg N., Joseph J., Kalyanaraman B. The oxidation of α-tocopherol and Trolox by peroxynitrite. Arch. Biochem. Biophys. 314:1994;153-158.
63. Lehrer-Graiwer J.E., Firestein B.L., Bredt D.S. Nitric oxide-mediated induction of cytochrome c oxidase mRNA and protein in a mouse macrophage cell line. Neurosci. Lett. 288:2000;107-110.
64. Wong-Riley M.T.T. Cytochrome oxidase an endogenous metabolic marker for neuronal activity . Trends Neurosci. 12:1989;94-101.
65. Zhang C., Wong-Riley M.T.T. Do nitric oxide synthase, NMDA receptor subunit R1, and cytochrome oxidase colocalize in the rat central nervous system? Brain Res. 729:1996;205-215.
66. Almeida A., Almeida J., Bolaos J.P., Moncada S. Different responses of astrocytes and neurons to nitric oxide the role of glycolytically generated ATP in astrocyte protection . Proc. Natl. Acad. Sci. USA. 98:2001;15294-15299.
67. Heales S.J.R., Bolaos J.P. Impairment of brain mitochondrial function by reactive nitrogen species the role of glutathione in dictating susceptibility . Neurochem. Int. 1157:2001;1-6.
68. Lizasoain I., Moro M.A., Knowles R.G., Darley-Usmar V., Moncada S. Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem. J. 314:1996;877-880.
69. Dringen R., Pfeiffer B., Hamprecht B. Synthesis of the antioxidant glutathione in neurons supply by astrocytes of cys-gly as precursor for neuronal glutathione . J. Neurosci. 19:1999;562-569.
70. Dringen R., Kranich O., Hamprecht B. The γ-glutamyltranspeptidase inhibitor acivicin preserves glutathione released by astroclial cells in culture. Neurochem. Res. 22:1997;727-733.
71. Stone R., Stewart V.C., Hurst R.D., Clark J.B., Heales S.J.R. Astrocyte nitric oxide causes neuronal mitochondrial damage but antioxidant release limits neuronal cell death. Ann. NY Acad. Sci. 893:1999;400-403.
72. Stewart V.C., Stone R., Gegg M.E., Sharpe M.A., Hurst R.D., Clark J.B., Heales S.J.R. Preservation of extracellular glutathione by an astrocyte-derived factor with properties comparable to superoxide dismutase. J. Neurochem. 83:2002;984-991.
73. Stewart V.C., Sharpe M.A., Clark J.B., Heales S.J.R. Astrocyte-derived nitric oxide causes both reversible and irreversible damage to the neuronal mitochondrial respiratory chain. J. Neurochem. 75:2000;694-700.
74. Makar T.K., Nedergraard M., Preuss A., Gelbard A.S., Perumal A.S., Cooper A.J.L. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurones evidence that astrocytes play an important role in antioxidative processes in the brain . J. Neurochem. 62:1994;45-53.
75. Stewart V.C., Land J.M., Clark J.B., Heales S.J.R. Pretreatment of astrocytes with interferon-α/β prevents neuronal mitochondrial respiratory chain damage. J. Neurochem. 70:1998;432-434.
76. Demerl-Pallardy C., Lonchampt M.O., Chabrier P.E., Braquet P. Nitric oxide synthase induction in glial cells effect on neuronal survival . Life Sci. 52:1993;1883-1890.
77. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 13:1994;487-494.
78. Dawson V.L., Brahmbhatt H.P., Mong J.A., Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology. 33:1994;1425-1430.
79. Corradin S.B., Maul J., Donini S.D., Quattrocchi E., Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 7:1993;255-262.
80. Boje K.M., Arora P.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
81. Stewart V.C., Clark J.B., Heales S.J.R. Comparing the effects of astrocytes and microglia on neurons in coculture. Eur. J. Neurosci. 2:(Suppl. 11):2000;354.
82. Merrill J., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
83. Ding M., St. Pierre B.A., Parkinson J.F., Medberry P., Wong J.L., Rogers N.E., Ignarro L.J., Merrill J.E. Inducible nitric oxide synthase and nitric oxide production in human fetal astrocytes and microglia. J. Biol. Chem. 272:1997;11327-11335.
84. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
85. Zhao M.L., Liu J.S.H., He D., Dickson D.W., Lee S.C. Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain. Brain Res. 813:1998;402-405.
86. McNaught K.S., Brown G.C. Nitric oxide causes glutamate release from brain synaptosomes. J. Neurochem. 70:1998;1541-1546.
87. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitoxicity. J. Neurosci. 21:2001;6480-6491.
88. Keelan J., Vergun O., Duchen M.R. Excitotoxic mitochondrial depolarization requires both calcium and nitric oxide in rat hippocampal neurons. J. Physiol. 520:1999;797-813.
89. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
90. Almeida A., Heales S.J.R., Bolaos J.P., Medina J.M. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. 790:1998;209-216.
91. Stewart V.C., Heslegrave A.J., Brown G.C., Clark J.B., Heales S.J.R. Nitric oxide-dependent damage to neuronal mitochondria involves the NMDA receptor. Eur. J. Neurosci. 15:2002;1-7.
92. Patneau D.K., Mayer M.L. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10:1990;2385-2399.
93. Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptor still lethal after eight years . Trends Neurosci. 18:1995;57-58.
94. Leist M., Nicotera P. Apoptosis, excitotoxicity, and neuropathology. Exp. Cell Res. 239:1998;183-201.
95. Reynolds I.J., Hastings T.G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15:1995;3318-3327.
96. Pauwels P.J., Leysen J.E. Blockade of nitric oxide formation does not prevent glutamate-induced neurotoxicity in neuronal cultures from rat hippocampus. Neurosci. Lett. 143:1992;27-30.
97. Garthwaite G., Garthwaite J. Nitric oxide does not mediate acute glutamate neurotoxicity, nor is it neuroprotective, in rat brain slices. Neuropharmacology. 33:1994;1431-1438.
98. Koh J.Y., Choi D.W. Vulnerability of cultured cortical neurons to damage by excitotoxins differential susceptibility of neurons containing NADPH-diaphorase . J. Neurosci. 8:1988;2153-2163.
99. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
100. Davey G.P., Canevari L., Clark J.B. Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions. J. Neurochem. 69:1997;2564-2570.
101. Davey G.P., Peuchen S., Clark J.B. Energy thresholds in brain mitochondria. J. Biol. Chem. 273:1998;12753-12757.
102. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death a succession of necrosis or apoptosis depending on mitochondrial function . Neuron. 15:1995;961-973.
103. Hartley A., Stone J.M., Heron C., Cooper J.M., Schapira A.H.V. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells relevance to Parkinson's disease . J. Neurochem. 63:1994;1987-1990.
104. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., Raff M.C. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature. 361:1993;365-369.
105. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241:1995;139-176.
106. Skulachev V.P. Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell. FEBS Lett. 397:1996;7-10.
107. Vercesi A.E., Kowalotoski A.J., Grijalba M.T., Meinicke A.R., Castilho R.F. The role of reactive oxygen species in mitochondrial permeability transition. Biosci. Rep. 17:1997;43-52.
108. Packer M.A., Murphy M.P. Peroxynitrite causes calcium efflux from mitochondria which is prevented by cyclosporin A. FEBS Lett. 345:1994;237-240.
109. Chavez E., Melendez E., Zazueta C., Reyes Viva H., Perales S.G. Membrane permeability transition induced by dysfunction of the electron transport chain. Biochem. Mol. Biol. Int. 41:1997;961-968.
110. Kristal B.S., Dubinsky J.M. Mitochondrial permeability transition in the central nervous system induction by calcium cycling-dependent and -independent pathways . J. Neurochem. 69:1997;524-538.
111. Nieminen A.L., Petrie T.G., LeMasters J.J., Selman W.R. Cyclosporin A delays mitochondrial depolarization induced by N-methyl-D-aspartate in cortical neurons evidence of the mitochondrial permeability transition . Neuroscience. 75:1996;993-997.
112. 2+-independent permeabilization of the inner mitochondrial membrane by peroxynitrite is mediated by membrane protein thiol cross-linking and lipid peroxidation. Arch. Biochem. Biophys. 345:1997;243-250.
113. Balakirev M.Y., Khramtsov V.V., Zimmer G. Modulation of the mitochondrial permeability transition by nitric oxide. Eur. J. Biochem. 246:1997;710-718.
114. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16:1993;125-131.
115. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L., White C.L. III, Araoz C. Brain interleukin-1 and S100 immunoreactivity are elevated in Alzheimer's disease and in Down's syndrome. Proc. Natl. Acad. Sci. USA. 865:1989;7611-7615.
116. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172:1994;151-154.
117. Schulz J.B., Matthews R.T., Beal M.F. Role of nitric oxide in neurodegenerative diseases. Curr. Opin. Neurol. 8:1995;480-486.
118. Hunot S., Boissiere F., Faucheux B., Brugg B., Mouattprigent A., Agid Y., Hirsch E.C. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience. 72:1996;355-363.
119. Shergill J.K., Cammack R., Cooper C.E., Cooper J.M., Mann V.M., Schapira A.H.V. Detection of nitrosyl complexes in human substantia nigra in relation to Parkinson's disease. Biochem. Biophys. Res. Commun. 228:1996;298-305.
120. Good P.F., Hsu A., Werner P., Perl D.P., Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57:1998;338-342.
121. Giasson B.I., Duda J.E., Murray I.V.J., Chen Q.P., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M.Y. Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science. 290:2000;985-989.
122. Qureshi G.A., Baia S.M., Parvez S. Neurotoxicity and possible roles of aspartic acid, glutamic acid, and GABA in some neurological disorders. Biogenic Amines. 13:1998;565-578.
123. Schapira A.H.V., Cooper J.M., Dexter D., Clark J.B., Jenner P., Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:1990;823-827.
124. Cleeter M.J.W., Cooper J.M., Schapira A.H.V. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium evidence for free radical involvement . J. Neurochem. 58:1992;786-789.
125. Glinka Y., Tipton K.F., Youdim M.B.H. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine. J. Neurochem. 66:1996;2004-2010.
126. Jenner P., Dexter D.T., Sian J., Schapira A.H.V., Marsden C.D. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann. Neurol. 32:1992;S82-S87.
127. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells relevance to Parkinson's Disease . Biochem. Pharmacol. 56:1998;645-655.
128. Heales S.J.R., Davies S.E.C., Bates T.E. Clark, J. B. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem. Res. 20:1995;31-38.
129. Sheu K.F.R., Kim Y.T., Blass J.P., Weksler M.E. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17:1985;444-449.
130. Sheu K.F.R., Cooper A.J.L., Koike K., Koike M., Lindsay J.G., Blass J.P. Abnormality of the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35:1994;312-318.
131. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
132. Dorheim M.A., Tracey W.R., Pollock J.S., Grammas P. Nitric oxide synthase activation is elevated in brain microvessels in Alzheimer's disease. Biochem. Biophys. Res. Commun. 205:1994;659-665.
133. Benzing W.C., Mufson E.J. Increased number of NADPH-D-positive neurons within the substantia innominata in Alzheimer's disease. Brain. 670:1995;351-355.
134. Smith M.A., Harris P.L.R., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17:1997;2653-2657.
135. Vodovotz Y., Lucia M.S., Flanders K.C., Chesler L., Xie Q.W., Smith T.W., Weinder J., Mumford R., Webber R., Nathan C., Roberts A.B., Lippa C.F., Sporn M.B. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J. Exp. Med. 184:1996;1425-1433.
136. Sheng J.G., Mrak R.E., Griffin W.S.T. S100β protein expression in Alzheimer's disease potential role in the pathogenesis of neuritic plaques . J. Neurosci. Res. 39:1994;398-404.
137. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
138. Rossi F., Bianchini E. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225:1996;474-478.
139. Wallace M.N., Geddes J.G., Farquhar D.A., Mason M.R. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques. Exp. Neurol. 144:1997;266-272.
140. Akama K.T., Albanese C., Pestell R.G., Van Eldik L.J. Amyloid β peptide stimulates nitric oxide production in astrocytes through an NF-κB-dependent mechanism. Proc. Natl. Acad. Sci. USA. 95:1998;5795-5800.
141. Canevari L., Casley C.S., Sharpe M.A., Land J.M. Amyloid β peptide inhibits mitochondrial enzymes and function. J. Neurochem. 76:(Suppl. 1):2001;30.
142. Canevari L., Clark J.B., Bates T.E. Beta-amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria. FEBS Lett. 457:1999;131-134.
143. Casley C.S., Canevari L., Land J.M., Clark J.B., Sharpe M.A. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80:2002;91-100.
144. Casley C.S., Sharpe M.A., Land J.M., Clark J.B., Canevari L. Beta-amyloid causes loss of neuronal mitochondrial function. J. Neurochem. 76:(Suppl. 1):2001;12.
145. Johnson A.W., Land J.M., Thompson E.J., Bolaos J.P., Clark J.B., Heales S.J.R. Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 57:1995;107.
146. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis. Ann. Neurol. 36:1994;778-786.
147. Bagasra O., Michaels F.H., Zheng Y.M., Bobroski L.E., Spitsin S.V., Fu Z.F., Tawadros R., Koprowski H. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;12041-12045.
148. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakada S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalitis. J. Neuroimmunol. 62:1995;103-112.
149. Grzybicki D., Kwack K.B., Perlman S., Murphy S. Nitric oxide synthase type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute vs. persistent virus infection. J. Neuroimmunol. 73:1997;15-27.
150. Thompson A.J., Miller D., Youl B., MacManus D., Moore S., Kingsley D., Kendall B., Feinstein A., McDonald W.I. Serial gadolinium enhanced MRI in relapsing/remitting multiple sclerosis. Neurology. 42:1992;60-63.
151. Hurst R.D., Fritz I.B. Nitric oxide induced perturbation in a cell culture model of the blood brain barrier. J. Cell Physiol. 167:1996;89-94.
152. Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction demyelinated axons are especially susceptible . Brain. 120:1997;2149-2157.
153. Lu F., Selak M., O'Connor J., Croul S., Lorenzana C., Butunoi C., Kalman B. Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J. Neurol. Sci. 177:2000;95-103.
154. Zielasek J., Reichmann H., Kunzig H., Jung S., Hartung H.P., Toyka K.V. Inhibition of brain microglial respiratory chain enzyme activity in experimental autoimmune encephalomyelitis of the Lewis rat. Neurosci. Lett. 184:1995;129-132.
155. Davies S.E.C., Newcombe J., Williams S.R., McDonald W.I., Clark J.B. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J. Neurochem. 64:1995;742-748.
156. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., Miller D.H., McDonald W.I. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
157. DeStefano N., Matthews P.M., Arnold D.L. Reversible decreases in N-acetyl aspartate after acute brain injury. Magn. Res. Med. 34:1995;721-727.
158. Nadier J.V., Cooper J.R. N-acetyl-L-aspartic acid content in human neural tumors and bovine peripheral nervous tissues. J. Neurochem. 19:1972;313-319.
159. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13:1993;981-989.
160. Bhakoo K.K., Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes implications for proton magnetic resonance spectroscopy signal in vivo . J. Neurochem. 74:2000;254-262.
161. Patel T.B., Clark J.B. Synthesis of N-acetyl-L-aspartate by rat mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 184:1979;539-546.
162. 1H MRS studies in vivo . Neuroreport. 7:1996;1397-1400.
163. Beckman J.S., Carson M., Smith C.D., Koppenol W.H. ALS, SOD, and peroxynitrite. Nature. 364:1993;584.
164. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;644-654.
165. Almer G., Vukovasic S., Romero N., Prezedborski S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial ALS. J. Neurochem. 72:1999;2415-2425.
166. Doroudchi M.M., Minotti S., Figlewicz D.A., Durham H.D. Nitrotyrosination contributes minimally to toxicity of mutant SOD1 associated with ALS. Neuroreport. 12:2001;1239-1243.
167. Collard J.F., Cote F., Julien J.P. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 375:1995;61-64.
168. Fujita K., Yamaucji M., Shibayama K., Ando M., Honda M., Nagata Y. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45:1996;276-281.
169. Zhen Y.W., Laverty R. Role of brain nitric oxide in 3,4-methylenedioxymethamphetamine- (MDMA-) induced neurotoxicity in rats. Brain Res. 795:1998;257-263.
170. Colado M.I., Camarero J., Meehan A.O., Sanchez V., Esteban B., Elliott J.M., Green A.R. A study of the mechanisms inolved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) on dopamine neurones in mouse brain. Br. J. Pharmacol. 134:2001;1711-1723.
171. Lin H.C., Kang B.H., Wong C.S., Mao S.P., Wan F.J. Systemic adminstration of D-amphetamine induced a delayed production of nitric oxide in the striatum of rats. Neurosci. Lett. 276:1999;141-144.
172. Burrows K.B., Gudelsky G., Yamamoto B.K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur. J. Pharmacol. 398:2000;11-18.
173. Devi B.G., Chan A.W.K. Impairment of mitochondrial respiration and electron transport chain enzymes during cocaine-induced hepatic injury. Life Sci. 60:1997;849-855.
174. Yuan C., Acosta D. Effect of cocaine on mitochondrial electron transport chain evaluated in primary cultures of neonatal rat myocardial cells and in isolated mitochondrial preparations. Drug Chem. Toxicol. 23:2000;339-348.
175. Veitch K., Hombroeck A., Caucheteux D., Pouleur H., Hue L. Global ischemia induces biphasic response of the mitochondrial respiratory chain. Biochem. J. 281:1992;709-715.
176. Browne S.E., Bowling A.C., Baik M.J., Gurney M., Brown R.H., Beal M.F. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J. Neurochem. 71:1998;281-287.
177. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L.R., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21:2001;3017-3023.
178. Nakao N., Ogura M., Nakai K., Itakura T. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J. Neurosci. 18:1998;1806-1817.
179. Murer M.G., Dziewczapolski G., Salin P., Vila M., Tseng K.Y., Ruberg M., Rubinstein M., Kelly M.A., Grandy D.K., Low M.J., Hirsch E., Raisman-Vozari R., Gershanik O. The indirect basal ganglia pathway in dopamine D-2 receptor-deficient mice. Neuroscience. 99:2000;643-650.
180. Bowling A.A., Schulz J.B., Brown R.H., Beal M.F. Superoxide dismutase activity, oxidative damage, and mtochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61:1993;2322-2325.
181. Matthews R.T., Beal M.F., Fallon J., Fedorchak K., Huang P.L., Fishman M.C., Hyman B.T. MPP+-induced substantia nigra degeneration is attenuated in nNOS knockout mice. Neurobiol. Dis. 4:1997;114-121.
182. Eliasson M.J., Huang Z., Ferrante R.J., Sasamata M., Molliver M.E., Snyder S.H., Moskowitz M.A. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci. 19:1999;5910-5918.
183. Imam S.Z., Newport G.D., Itzhak Y., Cadet J.L., Islam F., Slikker W. Jr, Ali S.F. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase . J. Neurochem. 76:2001;745-749.
184. Azad S.C., Marsicano G., Eberlein I., Putzke J., Zieglgansberger W., Spanagel R., Lutz B. Differential role of the nitric oxide pathway on δ(9)-THC-induced central nervous system effects in the mouse. Eur. J. Neurosci. 13:2001;561-568.
185. Weinstock-Guttman B., Ransohoff R.M., Kinkel R.P., Rudick R.A. The interferons biological effects, mechanisms of action, and use in multiple sclerosis . Ann. Neurol. 36:1995;7-15.
186. Hua L.L., Liu S.J.H., Brosnan C.F., Lee S.C. Selective inhibition of human glial inducible nitric oxide synthase by interferon-β implications for multiple sclerosis . Ann. Neurol. 43:1998;384-387.
187. Shigenaga M.K., Hagen T.M., Ames B.N. Oxidative damage and mitochondrial decay in aging. Proc. Natl. Acad. Sci. USA. 91:1994;10771-10778.
188. Miquel J., Ferrandiz M.L., De Juan E., Sevila I., Martinez M. N-acetylcysteine protects against age-related decline of oxidative phosphorylation in liver mitochondria. Eur. J. Pharmacol. 292:1995;333-335.
189. Banaclocha M.M. N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice implications for treatment of Parkinson's disease . Brain Res. 859:2000;173-175.
190. Meister A., Tata S.S., Griffith O.W. Gamma-glutamyltranspeptidase. Methods Enzymol. 77:1981;237-253.
191. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18:1998;2040-2055.
192. Reiter R.J., Acuna-Castroviejo D., Tan D.X., Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. NY Acad. Sci. 939:2001;200-215.
193. Dabbeni-Sala F., Di Santo S., Franceschini D., Skaper S.D., Giusti P. Melatonin protects against 6-OHDA-induced neurotoxicity in rats a role for mitochondrial complex I activity . FASEB J. 15:2001;164-170.
194. Molina-Holgado F., Lledo A., Guaza C. Anandamide suppresses nitric oxide and TNF-α responses to Theiler's virus or endotoxin in astrocytes. Neuroreport. 8:1997;1929-1933.
195. Waksman Y., Olson J., Carlisle S.J., Cabral G.A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288:1999;1357-1366.
196. Esposito G., Izzo A.A., DiRosa M., Iuvone T. Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. J. Neurochem. 78:2001;835-841.
197. Marsicano G., Moosmann B., Hermann H., Lutz B., Behl C. Neuroprotective properties of cannabinoids against oxidative stress role of the cannabinoid receptor CB1 . J. Neurochem. 80:2002;448-456.